Avanos Medical Inc (AVNS) Stock Forecast & Price Target
Avanos Medical Inc · NYSE
$24.99+0.01 (+0.04%)
15-min delayed · Jul 24, 3:45 PM ET · Get real-time quotes →
ANALYST CONSENSUS0 ratings
No Rating
Strong Buy00%
Buy00%
Hold00%
Sell00%
Strong Sell00%
Analyst rating coverage is not available for AVNS yet.
12-MONTH PRICE TARGET
—
Average analyst target vs $24.99 current
Highest Target—
Average Target—
Lowest Target—
AVNS EPS & revenue forecast
EPS · NEXT QUARTER
$0.33
Range $0.33 – $0.33 · 1 analysts · +50% YoY
Next period, 1 analysts expect Avanos Medical Inc to earn $0.33 a share (range $0.33 – $0.33), versus $0.22 a year earlier. Full-year consensus is $1.00, growing to $1.25 the year after.
REVENUE · NEXT QUARTER
$181.0M
Range $181.0M – $181.0M · 1 analysts · +2% YoY
Revenue is expected to reach $181.0M (range $181.0M – $181.0M), +2.0% year-over-year. Full-year consensus is $710.0M, rising to $740.0M next year.
AVNS stock forecast FAQ
What is Avanos Medical Inc's projected EPS for next quarter?+
The consensus estimate is $0.33 per share (range $0.33 – $0.33) across 1 analysts. Full-year EPS is projected at $1.00, rising to $1.25 the following year.
How much revenue is Avanos Medical Inc expected to report next quarter?+
Consensus revenue is $181.0M (range $181.0M – $181.0M). Full-year revenue is projected at $710.0M, growing to $740.0M next year.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their AVNS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
